Want to see IN:FISCHER full AI Analyst Report?
FISCHER Stock Chart & Stats
₹43.67
--
Market closed
₹43.67
--
Day’s Range― - ―
52-Week Range₹29.10 - ₹121.45
Previous CloseN/A
VolumeN/A
Average Volume (3M)61.84K
Market Cap
₹19.26B
Enterprise Value₹27.27B
Total Cash (Recent Filing)₹250.46M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)64.8
Beta0.41
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.17%
Share Statistics
EPS (TTM)0.46
Shares Outstanding654,515,440
10 Day Avg. Volume44,946
30 Day Avg. Volume61,837
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)6.83
Price to Sales (P/S)8.52
P/FCF Ratio-20.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe sharp FY2026 revenue increase indicates materially greater business scale and customer activity than the prior year. If the higher revenue base is sustained, it can support operating leverage, improve resource efficiency, and provide a stronger foundation for future earnings growth.
Profitability ImprovementMeaningful margin expansion shows that FY2026 growth translated into stronger accounting profitability rather than revenue alone. Sustained margins at these levels would improve earnings quality, strengthen internal funding capacity, and make the company more resilient to moderate cost or revenue pressure.
Manageable LeverageRecent leverage appears manageable relative to the enlarged equity base, giving the company more balance-sheet capacity than in its weaker historical periods. A stronger capital position can support continued operations and investment while reducing immediate pressure from debt service and refinancing needs.
Bears Say
Persistent Cash BurnDeeply negative operating and free cash flow is a significant concern because reported profitability is not currently converting into cash. Continued cash burn can increase reliance on external funding, limit financial flexibility, and undermine the sustainability of growth unless cash generation improves.
Historical Earnings VolatilityThe progression from no revenue to historical losses and then a strong FY2026 result shows a volatile operating record. That history makes it harder to establish a dependable earnings base and increases the risk that recent growth and margin gains may not persist across future reporting periods.
Debt Increase And Capital RiskAlthough current leverage is described as manageable, the substantial increase in debt and earlier negative equity reveal a materially changed and historically fragile capital structure. This raises execution and financing risk, particularly if cash generation remains negative or recent profitability weakens.
Fischer Medical Ventures Ltd News
FISCHER FAQ
What was Fischer Medical Ventures Ltd’s price range in the past 12 months?
Fischer Medical Ventures Ltd lowest stock price was ₹29.10 and its highest was ₹121.45 in the past 12 months.
What is Fischer Medical Ventures Ltd’s market cap?
Fischer Medical Ventures Ltd’s market cap is ₹19.26B.
When is Fischer Medical Ventures Ltd’s upcoming earnings report date?
Fischer Medical Ventures Ltd’s upcoming earnings report date is Nov 12, 2026 which is in 25 days.
How were Fischer Medical Ventures Ltd’s earnings last quarter?
Fischer Medical Ventures Ltd released its earnings results on Aug 14, 2026. The company reported ₹0.058 earnings per share for the quarter.
Is Fischer Medical Ventures Ltd overvalued?
According to Wall Street analysts Fischer Medical Ventures Ltd’s price is currently Overvalued.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd pays a Annually dividend of ₹0.05 which represents an annual dividend yield of 0.17%. See more information on Fischer Medical Ventures Ltd dividends here
What is Fischer Medical Ventures Ltd’s EPS estimate?
Fischer Medical Ventures Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fischer Medical Ventures Ltd have?
Fischer Medical Ventures Ltd has 654,515,440 shares outstanding.
What happened to Fischer Medical Ventures Ltd’s price movement after its last earnings report?
Fischer Medical Ventures Ltd reported an EPS of ₹0.058 in its last earnings report. Following the earnings report the stock price went down -0.337%.
Which hedge fund is a major shareholder of Fischer Medical Ventures Ltd?
Currently, no hedge funds are holding shares in IN:FISCHER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fischer Medical Ventures Ltd
Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Technical Analysis
Aarti Pharmalabs Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Thyrocare Technologies Ltd
―